期刊文献+

大黄酸-雌激素偶联物的合成及其药理学活性 被引量:12

Synthesis and pharmacological activities of a series of estrogen-rhein hybrid compounds
下载PDF
导出
摘要 目的:设计并合成大黄酸-雌激素偶联物,以期在保留雌激素对骨的作用的同时降低其对子宫内膜增殖的刺激。方法:经雌酚酮或雌二醇3-位酚羟基以烷基哌嗪或聚乙二醇哌嗪为桥合成与大黄酸相连的衍生物,通过MS,1HNMR,IR确定结构,并研究目标化合物对小鼠子宫内膜增殖的影响、对体外培养小鼠胚胎长骨生长的影响。结果:合成的10个目标化合物中,部分目标物能促进体外培养小鼠胚胎长骨的生长,桥链为乙基或丙基时,化合物的活性较雌酚酮相比减弱,当桥链为三聚乙二醇时,对骨的促生长活性增强。所测定的目标物均未对小鼠显示出刺激子宫内膜增殖的作用。结论:大黄酸-雌激素偶联物保留了雌激素对骨的作用,且降低了其对子宫内膜增殖的刺激作用。 Aim: To design and synthesize the estrogen-rhein hybrid compounds to decrease the simulating effect of estrgen on endometrium and maintaining the effect on bone. Methods: The compounds that link rhein to estrone or estadiol respectively through ethyl-piperazinyl, propyl-piperazinyl, butyl-piperazinyl, diethylene glycol-piperazinyl and triethylene glycol-piperazinyl were synthesized. The structures of these compounds were confirmed by MS, ^1 H NMR and IR. The effects of target compounds that link rhein to estrone on long bones of fetal mice in vitro and on the endometrium of mice in vivo were studied. Results:Ten target compounds were synthesized.Some target compounds showed the activity of enhancing long bone growth in fetal mouse in vitro. The activity of the compound was lower than estrone when it was linked to ethyl-piperazinyl or propyl-piperazinyl, and stronger than estrone when it was linked to triethylene glycol-piperazinyl. No activity of stimulating proliferation in endometrium was observed in all the target compounds. Conclusion: The results suggested that the beneficial influence on the bone of estrogen has been remained and the side effects on endometrium have been decreased in these rhein-estrogen synthesized.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2007年第1期6-11,共6页 Journal of China Pharmaceutical University
基金 天津市归国人员课题资助项目(No.033609811) 武警总部科研基金资助项目(No.WKH2004-8)~~
关键词 雌激素 大黄酸 偶联物 合成 子宫内膜 estrogen rhein hybrid compound synthesis endometrium
  • 相关文献

参考文献9

  • 1Uludag H,Yang J.Targeting systemically administered proteins to bone by bisphosphonate conjugation[J].Biotechnol Prog,2002,18(3):604-611.
  • 2Tsusashi N,Yabuki M,Harada H,et al.Tissue distribution and pharmacological potential of SM-16869,a novel oestrogen-bisphosponate hybrid compound[J].J Pharm Pharmacol,2000,52(1):27-37.
  • 3Zheng H,Weng LL.Bone-resorption inhibition/osteogenesis pro-motion pharmaceutical composition:US,6028207[P].2000-02-22.
  • 4Yokogawa K,Miya K,Sekido T,et al.Selective delivery of estradiol to bone by aspartic oligopeptide and its effects on ovariectomized mice[J].Endocrinology,2001,142(3):1 128-1 133.
  • 5Sekido T,Sakura N,Higashi Y,et al.Novel drug delivery system to bone using acidic oligopeptide pharmacokinetic characteristics and pharmacological potential[J].J Drug Target,2001,9(2):111-121.
  • 6张苹(ZhangP) 徐军(XuJ) 庞淑珍(PangSZ) 等.大黄蒽醌衍生物对破骨细胞性骨吸收作用的研究[J].北京医科大学学报,1998,30:25-29.
  • 7李灵芝,宋艳.雌甾3-位酚羟基相转移催化醚化[J].中国药科大学学报,1999,30(4):319-320. 被引量:1
  • 8李灵芝,郑虎,翁玲玲.骨靶向雌激素中间体──雌激素哌嗪衍生物的合成[J].武警后勤学院学报(医学版),1999,20(1):10-17. 被引量:2
  • 9刘开泰,马丽英,李灵芝,王瑞淑,王国荃,汪师贞.骨器官体外培养的方法学研究[J].新疆医科大学学报,2001,24(1):8-10. 被引量:5

二级参考文献5

  • 1楼荣良,翁玲玲,郑虎.功能化雌激素乙二醇化合物的合成[J].中国药物化学杂志,1997,7(1):33-36. 被引量:4
  • 2Dutta PL,Foye WA.Syntnesis and biological activity of a scries of asparate transcarbamoylase inhibitors: diethyl aspartates and N—substituted—3—oxo—1,4—piperazine—2一acetic acid estersJournal of Pharmacological Sciences,1990.
  • 3Komm BS,Terpening CM,Benz DJ.Estrogen binding,receptor mRNA, and biologic response in osteoblast likecells. Science . 1988
  • 4Eriksen EF,Colvard DS,Berg NJ,et al.Evidence of estrogenreceptors in normal human osteoblast-like cells. Science . 1988
  • 5李灵芝,郑虎.β-氯乙基-3-O-雌酚酮醚合成方法改进[J].华西药学杂志,1998,13(2):105-105. 被引量:4

共引文献5

同被引文献157

引证文献12

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部